img

Global Anti-infectious Disease Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-infectious Disease Drugs Market Insights, Forecast to 2034

Global Anti-infectious Disease Drugs market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Anti-infectious Disease Drugs industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Anti-infectious Disease Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Anti-infectious Disease Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Aridis Pharmaceuticals
AiCuris
Sandoz
Anhui Jingfang Medical Industry Co.,Ltd
Beijing Double-Crane Pharmaceutical Co., Ltd.
Abbott
Spero Therapeutics
Adlyfe, Inc.
Advanced Life Sciences Holdings, Inc.
Affinium Pharmaceuticals
APP Pharmaceuticals
Aquapharm Biodiscovery
Basilea Pharmaceutica AG
Biophage Pharma, Inc.
Segment by Type
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Antiparasitic Drugs

Segment by Application


Hospital
Institute of Medicine
Clinic
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Anti-infectious Disease Drugs plant distribution, commercial date of Anti-infectious Disease Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Anti-infectious Disease Drugs introduction, etc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Anti-infectious Disease Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Anti-infectious Disease Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-infectious Disease Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antibacterial Drugs
1.2.3 Antifungal Drugs
1.2.4 Antiviral Drugs
1.2.5 Antiparasitic Drugs
1.3 Market by Application
1.3.1 Global Anti-infectious Disease Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Institute of Medicine
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-infectious Disease Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Anti-infectious Disease Drugs Revenue by Region
2.2.1 Global Anti-infectious Disease Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Anti-infectious Disease Drugs Revenue by Region (2018-2024)
2.2.3 Global Anti-infectious Disease Drugs Revenue by Region (2024-2029)
2.2.4 Global Anti-infectious Disease Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Anti-infectious Disease Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Anti-infectious Disease Drugs Sales by Region
2.4.1 Global Anti-infectious Disease Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Anti-infectious Disease Drugs Sales by Region (2018-2024)
2.4.3 Global Anti-infectious Disease Drugs Sales by Region (2024-2029)
2.4.4 Global Anti-infectious Disease Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Anti-infectious Disease Drugs Sales by Manufacturers
3.1.1 Global Anti-infectious Disease Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Anti-infectious Disease Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-infectious Disease Drugs in 2022
3.2 Global Anti-infectious Disease Drugs Revenue by Manufacturers
3.2.1 Global Anti-infectious Disease Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Anti-infectious Disease Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Anti-infectious Disease Drugs Revenue in 2022
3.3 Global Key Players of Anti-infectious Disease Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Anti-infectious Disease Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-infectious Disease Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-infectious Disease Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Anti-infectious Disease Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-infectious Disease Drugs Sales by Type
4.1.1 Global Anti-infectious Disease Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Anti-infectious Disease Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Anti-infectious Disease Drugs Sales Market Share by Type (2018-2029)
4.2 Global Anti-infectious Disease Drugs Revenue by Type
4.2.1 Global Anti-infectious Disease Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Anti-infectious Disease Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Anti-infectious Disease Drugs Price by Type
4.3.1 Global Anti-infectious Disease Drugs Price by Type (2018-2024)
4.3.2 Global Anti-infectious Disease Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Anti-infectious Disease Drugs Sales by Application
5.1.1 Global Anti-infectious Disease Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Anti-infectious Disease Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Anti-infectious Disease Drugs Sales Market Share by Application (2018-2029)
5.2 Global Anti-infectious Disease Drugs Revenue by Application
5.2.1 Global Anti-infectious Disease Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Anti-infectious Disease Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Anti-infectious Disease Drugs Price by Application
5.3.1 Global Anti-infectious Disease Drugs Price by Application (2018-2024)
5.3.2 Global Anti-infectious Disease Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Anti-infectious Disease Drugs Market Size by Type
6.1.1 US & Canada Anti-infectious Disease Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Anti-infectious Disease Drugs Revenue by Type (2018-2029)
6.2 US & Canada Anti-infectious Disease Drugs Market Size by Application
6.2.1 US & Canada Anti-infectious Disease Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Anti-infectious Disease Drugs Revenue by Application (2018-2029)
6.3 US & Canada Anti-infectious Disease Drugs Market Size by Country
6.3.1 US & Canada Anti-infectious Disease Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Anti-infectious Disease Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Anti-infectious Disease Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Anti-infectious Disease Drugs Market Size by Type
7.1.1 Europe Anti-infectious Disease Drugs Sales by Type (2018-2029)
7.1.2 Europe Anti-infectious Disease Drugs Revenue by Type (2018-2029)
7.2 Europe Anti-infectious Disease Drugs Market Size by Application
7.2.1 Europe Anti-infectious Disease Drugs Sales by Application (2018-2029)
7.2.2 Europe Anti-infectious Disease Drugs Revenue by Application (2018-2029)
7.3 Europe Anti-infectious Disease Drugs Market Size by Country
7.3.1 Europe Anti-infectious Disease Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Anti-infectious Disease Drugs Sales by Country (2018-2029)
7.3.3 Europe Anti-infectious Disease Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Anti-infectious Disease Drugs Market Size
8.1.1 China Anti-infectious Disease Drugs Sales (2018-2029)
8.1.2 China Anti-infectious Disease Drugs Revenue (2018-2029)
8.2 China Anti-infectious Disease Drugs Market Size by Application
8.2.1 China Anti-infectious Disease Drugs Sales by Application (2018-2029)
8.2.2 China Anti-infectious Disease Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Anti-infectious Disease Drugs Market Size by Type
9.1.1 Asia Anti-infectious Disease Drugs Sales by Type (2018-2029)
9.1.2 Asia Anti-infectious Disease Drugs Revenue by Type (2018-2029)
9.2 Asia Anti-infectious Disease Drugs Market Size by Application
9.2.1 Asia Anti-infectious Disease Drugs Sales by Application (2018-2029)
9.2.2 Asia Anti-infectious Disease Drugs Revenue by Application (2018-2029)
9.3 Asia Anti-infectious Disease Drugs Sales by Region
9.3.1 Asia Anti-infectious Disease Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Anti-infectious Disease Drugs Revenue by Region (2018-2029)
9.3.3 Asia Anti-infectious Disease Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-infectious Disease Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Anti-infectious Disease Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Aridis Pharmaceuticals
11.1.1 Aridis Pharmaceuticals Company Information
11.1.2 Aridis Pharmaceuticals Overview
11.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aridis Pharmaceuticals Recent Developments
11.2 AiCuris
11.2.1 AiCuris Company Information
11.2.2 AiCuris Overview
11.2.3 AiCuris Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AiCuris Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AiCuris Recent Developments
11.3 Sandoz
11.3.1 Sandoz Company Information
11.3.2 Sandoz Overview
11.3.3 Sandoz Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sandoz Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sandoz Recent Developments
11.4 Anhui Jingfang Medical Industry Co.,Ltd
11.4.1 Anhui Jingfang Medical Industry Co.,Ltd Company Information
11.4.2 Anhui Jingfang Medical Industry Co.,Ltd Overview
11.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Anhui Jingfang Medical Industry Co.,Ltd Recent Developments
11.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
11.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Company Information
11.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Overview
11.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments
11.6 Abbott
11.6.1 Abbott Company Information
11.6.2 Abbott Overview
11.6.3 Abbott Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Abbott Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Abbott Recent Developments
11.7 Spero Therapeutics
11.7.1 Spero Therapeutics Company Information
11.7.2 Spero Therapeutics Overview
11.7.3 Spero Therapeutics Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Spero Therapeutics Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Spero Therapeutics Recent Developments
11.8 Adlyfe, Inc.
11.8.1 Adlyfe, Inc. Company Information
11.8.2 Adlyfe, Inc. Overview
11.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Adlyfe, Inc. Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Adlyfe, Inc. Recent Developments
11.9 Advanced Life Sciences Holdings, Inc.
11.9.1 Advanced Life Sciences Holdings, Inc. Company Information
11.9.2 Advanced Life Sciences Holdings, Inc. Overview
11.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Advanced Life Sciences Holdings, Inc. Recent Developments
11.10 Affinium Pharmaceuticals
11.10.1 Affinium Pharmaceuticals Company Information
11.10.2 Affinium Pharmaceuticals Overview
11.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Affinium Pharmaceuticals Recent Developments
11.11 APP Pharmaceuticals
11.11.1 APP Pharmaceuticals Company Information
11.11.2 APP Pharmaceuticals Overview
11.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 APP Pharmaceuticals Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 APP Pharmaceuticals Recent Developments
11.12 Aquapharm Biodiscovery
11.12.1 Aquapharm Biodiscovery Company Information
11.12.2 Aquapharm Biodiscovery Overview
11.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aquapharm Biodiscovery Recent Developments
11.13 Basilea Pharmaceutica AG
11.13.1 Basilea Pharmaceutica AG Company Information
11.13.2 Basilea Pharmaceutica AG Overview
11.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Basilea Pharmaceutica AG Recent Developments
11.14 Biophage Pharma, Inc.
11.14.1 Biophage Pharma, Inc. Company Information
11.14.2 Biophage Pharma, Inc. Overview
11.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Biophage Pharma, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-infectious Disease Drugs Industry Chain Analysis
12.2 Anti-infectious Disease Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-infectious Disease Drugs Production Mode & Process
12.4 Anti-infectious Disease Drugs Sales and Marketing
12.4.1 Anti-infectious Disease Drugs Sales Channels
12.4.2 Anti-infectious Disease Drugs Distributors
12.5 Anti-infectious Disease Drugs Customers
13 Market Dynamics
13.1 Anti-infectious Disease Drugs Industry Trends
13.2 Anti-infectious Disease Drugs Market Drivers
13.3 Anti-infectious Disease Drugs Market Challenges
13.4 Anti-infectious Disease Drugs Market Restraints
14 Key Findings in The Global Anti-infectious Disease Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-infectious Disease Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Antibacterial Drugs
Table 3. Major Manufacturers of Antifungal Drugs
Table 4. Major Manufacturers of Antiviral Drugs
Table 5. Major Manufacturers of Antiparasitic Drugs
Table 6. Global Anti-infectious Disease Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Anti-infectious Disease Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Anti-infectious Disease Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Anti-infectious Disease Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Anti-infectious Disease Drugs Revenue Market Share by Region (2018-2024)
Table 11. Global Anti-infectious Disease Drugs Revenue Market Share by Region (2024-2029)
Table 12. Global Anti-infectious Disease Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Anti-infectious Disease Drugs Sales by Region (2018-2024) & (K Units)
Table 14. Global Anti-infectious Disease Drugs Sales by Region (2024-2029) & (K Units)
Table 15. Global Anti-infectious Disease Drugs Sales Market Share by Region (2018-2024)
Table 16. Global Anti-infectious Disease Drugs Sales Market Share by Region (2024-2029)
Table 17. Global Anti-infectious Disease Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Anti-infectious Disease Drugs Sales Share by Manufacturers (2018-2024)
Table 19. Global Anti-infectious Disease Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Anti-infectious Disease Drugs Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Anti-infectious Disease Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Anti-infectious Disease Drugs Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Anti-infectious Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Anti-infectious Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-infectious Disease Drugs as of 2022)
Table 25. Global Key Manufacturers of Anti-infectious Disease Drugs, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Anti-infectious Disease Drugs, Product Offered and Application
Table 27. Global Key Manufacturers of Anti-infectious Disease Drugs, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Anti-infectious Disease Drugs Sales by Type (2018-2024) & (K Units)
Table 30. Global Anti-infectious Disease Drugs Sales by Type (2024-2029) & (K Units)
Table 31. Global Anti-infectious Disease Drugs Sales Share by Type (2018-2024)
Table 32. Global Anti-infectious Disease Drugs Sales Share by Type (2024-2029)
Table 33. Global Anti-infectious Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Anti-infectious Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Anti-infectious Disease Drugs Revenue Share by Type (2018-2024)
Table 36. Global Anti-infectious Disease Drugs Revenue Share by Type (2024-2029)
Table 37. Anti-infectious Disease Drugs Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Anti-infectious Disease Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Anti-infectious Disease Drugs Sales by Application (2018-2024) & (K Units)
Table 40. Global Anti-infectious Disease Drugs Sales by Application (2024-2029) & (K Units)
Table 41. Global Anti-infectious Disease Drugs Sales Share by Application (2018-2024)
Table 42. Global Anti-infectious Disease Drugs Sales Share by Application (2024-2029)
Table 43. Global Anti-infectious Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Anti-infectious Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Anti-infectious Disease Drugs Revenue Share by Application (2018-2024)
Table 46. Global Anti-infectious Disease Drugs Revenue Share by Application (2024-2029)
Table 47. Anti-infectious Disease Drugs Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Anti-infectious Disease Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Anti-infectious Disease Drugs Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Anti-infectious Disease Drugs Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Anti-infectious Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Anti-infectious Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Anti-infectious Disease Drugs Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Anti-infectious Disease Drugs Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Anti-infectious Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Anti-infectious Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Anti-infectious Disease Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Anti-infectious Disease Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Anti-infectious Disease Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Anti-infectious Disease Drugs Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Anti-infectious Disease Drugs Sales by Country (2024-2029) & (K Units)
Table 62. Europe Anti-infectious Disease Drugs Sales by Type (2018-2024) & (K Units)
Table 63. Europe Anti-infectious Disease Drugs Sales by Type (2024-2029) & (K Units)
Table 64. Europe Anti-infectious Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Anti-infectious Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Anti-infectious Disease Drugs Sales by Application (2018-2024) & (K Units)
Table 67. Europe Anti-infectious Disease Drugs Sales by Application (2024-2029) & (K Units)
Table 68. Europe Anti-infectious Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Anti-infectious Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Anti-infectious Disease Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Anti-infectious Disease Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Anti-infectious Disease Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Anti-infectious Disease Drugs Sales by Country (2018-2024) & (K Units)
Table 74. Europe Anti-infectious Disease Drugs Sales by Country (2024-2029) & (K Units)
Table 75. China Anti-infectious Disease Drugs Sales by Type (2018-2024) & (K Units)
Table 76. China Anti-infectious Disease Drugs Sales by Type (2024-2029) & (K Units)
Table 77. China Anti-infectious Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Anti-infectious Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Anti-infectious Disease Drugs Sales by Application (2018-2024) & (K Units)
Table 80. China Anti-infectious Disease Drugs Sales by Application (2024-2029) & (K Units)
Table 81. China Anti-infectious Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Anti-infectious Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Anti-infectious Disease Drugs Sales by Type (2018-2024) & (K Units)
Table 84. Asia Anti-infectious Disease Drugs Sales by Type (2024-2029) & (K Units)
Table 85. Asia Anti-infectious Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Anti-infectious Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Anti-infectious Disease Drugs Sales by Application (2018-2024) & (K Units)
Table 88. Asia Anti-infectious Disease Drugs Sales by Application (2024-2029) & (K Units)
Table 89. Asia Anti-infectious Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Anti-infectious Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Anti-infectious Disease Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Anti-infectious Disease Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Anti-infectious Disease Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Anti-infectious Disease Drugs Sales by Region (2018-2024) & (K Units)
Table 95. Asia Anti-infectious Disease Drugs Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales by Country (2024-2029) & (K Units)
Table 109. Aridis Pharmaceuticals Company Information
Table 110. Aridis Pharmaceuticals Description and Major Businesses
Table 111. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Aridis Pharmaceuticals Recent Developments
Table 114. AiCuris Company Information
Table 115. AiCuris Description and Major Businesses
Table 116. AiCuris Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. AiCuris Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. AiCuris Recent Developments
Table 119. Sandoz Company Information
Table 120. Sandoz Description and Major Businesses
Table 121. Sandoz Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Sandoz Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Sandoz Recent Developments
Table 124. Anhui Jingfang Medical Industry Co.,Ltd Company Information
Table 125. Anhui Jingfang Medical Industry Co.,Ltd Description and Major Businesses
Table 126. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Anhui Jingfang Medical Industry Co.,Ltd Recent Developments
Table 129. Beijing Double-Crane Pharmaceutical Co., Ltd. Company Information
Table 130. Beijing Double-Crane Pharmaceutical Co., Ltd. Description and Major Businesses
Table 131. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments
Table 134. Abbott Company Information
Table 135. Abbott Description and Major Businesses
Table 136. Abbott Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Abbott Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Abbott Recent Developments
Table 139. Spero Therapeutics Company Information
Table 140. Spero Therapeutics Description and Major Businesses
Table 141. Spero Therapeutics Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Spero Therapeutics Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Spero Therapeutics Recent Developments
Table 144. Adlyfe, Inc. Company Information
Table 145. Adlyfe, Inc. Description and Major Businesses
Table 146. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Adlyfe, Inc. Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Adlyfe, Inc. Recent Developments
Table 149. Advanced Life Sciences Holdings, Inc. Company Information
Table 150. Advanced Life Sciences Holdings, Inc. Description and Major Businesses
Table 151. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Advanced Life Sciences Holdings, Inc. Recent Developments
Table 154. Affinium Pharmaceuticals Company Information
Table 155. Affinium Pharmaceuticals Description and Major Businesses
Table 156. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Affinium Pharmaceuticals Recent Developments
Table 159. APP Pharmaceuticals Company Information
Table 160. APP Pharmaceuticals Description and Major Businesses
Table 161. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. APP Pharmaceuticals Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. APP Pharmaceuticals Recent Developments
Table 164. Aquapharm Biodiscovery Company Information
Table 165. Aquapharm Biodiscovery Description and Major Businesses
Table 166. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Aquapharm Biodiscovery Recent Developments
Table 169. Basilea Pharmaceutica AG Company Information
Table 170. Basilea Pharmaceutica AG Description and Major Businesses
Table 171. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Basilea Pharmaceutica AG Recent Developments
Table 174. Biophage Pharma, Inc. Company Information
Table 175. Biophage Pharma, Inc. Description and Major Businesses
Table 176. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Biophage Pharma, Inc. Recent Developments
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Anti-infectious Disease Drugs Distributors List
Table 182. Anti-infectious Disease Drugs Customers List
Table 183. Anti-infectious Disease Drugs Market Trends
Table 184. Anti-infectious Disease Drugs Market Drivers
Table 185. Anti-infectious Disease Drugs Market Challenges
Table 186. Anti-infectious Disease Drugs Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-infectious Disease Drugs Product Picture
Figure 2. Global Anti-infectious Disease Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Anti-infectious Disease Drugs Market Share by Type in 2022 & 2029
Figure 4. Antibacterial Drugs Product Picture
Figure 5. Antifungal Drugs Product Picture
Figure 6. Antiviral Drugs Product Picture
Figure 7. Antiparasitic Drugs Product Picture
Figure 8. Global Anti-infectious Disease Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Anti-infectious Disease Drugs Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Institute of Medicine
Figure 12. Clinic
Figure 13. Others
Figure 14. Anti-infectious Disease Drugs Report Years Considered
Figure 15. Global Anti-infectious Disease Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Anti-infectious Disease Drugs Revenue 2018-2029 (US$ Million)
Figure 17. Global Anti-infectious Disease Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Anti-infectious Disease Drugs Revenue Market Share by Region (2018-2029)
Figure 19. Global Anti-infectious Disease Drugs Sales 2018-2029 ((K Units)
Figure 20. Global Anti-infectious Disease Drugs Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Anti-infectious Disease Drugs Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Anti-infectious Disease Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Anti-infectious Disease Drugs Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Anti-infectious Disease Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Anti-infectious Disease Drugs Sales YoY (2018-2029) & (K Units)
Figure 26. China Anti-infectious Disease Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Anti-infectious Disease Drugs Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Anti-infectious Disease Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Anti-infectious Disease Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Anti-infectious Disease Drugs in the World: Market Share by Anti-infectious Disease Drugs Revenue in 2022
Figure 33. Global Anti-infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Anti-infectious Disease Drugs Sales Market Share by Type (2018-2029)
Figure 35. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 36. Global Anti-infectious Disease Drugs Sales Market Share by Application (2018-2029)
Figure 37. Global Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Anti-infectious Disease Drugs Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Anti-infectious Disease Drugs Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Anti-infectious Disease Drugs Revenue Share by Country (2018-2029)
Figure 43. US & Canada Anti-infectious Disease Drugs Sales Share by Country (2018-2029)
Figure 44. U.S. Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Anti-infectious Disease Drugs Sales Market Share by Type (2018-2029)
Figure 47. Europe Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 48. Europe Anti-infectious Disease Drugs Sales Market Share by Application (2018-2029)
Figure 49. Europe Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 50. Europe Anti-infectious Disease Drugs Revenue Share by Country (2018-2029)
Figure 51. Europe Anti-infectious Disease Drugs Sales Share by Country (2018-2029)
Figure 52. Germany Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. France Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. China Anti-infectious Disease Drugs Sales Market Share by Type (2018-2029)
Figure 58. China Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 59. China Anti-infectious Disease Drugs Sales Market Share by Application (2018-2029)
Figure 60. China Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 61. Asia Anti-infectious Disease Drugs Sales Market Share by Type (2018-2029)
Figure 62. Asia Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 63. Asia Anti-infectious Disease Drugs Sales Market Share by Application (2018-2029)
Figure 64. Asia Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 65. Asia Anti-infectious Disease Drugs Revenue Share by Region (2018-2029)
Figure 66. Asia Anti-infectious Disease Drugs Sales Share by Region (2018-2029)
Figure 67. Japan Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. India Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Anti-infectious Disease Drugs Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Anti-infectious Disease Drugs Sales Share by Country (2018-2029)
Figure 78. Brazil Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Anti-infectious Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 83. Anti-infectious Disease Drugs Value Chain
Figure 84. Anti-infectious Disease Drugs Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed